» Articles » PMID: 23045983

Development of Cell-active N6-methyladenosine RNA Demethylase FTO Inhibitor

Abstract

The direct nucleic acid repair dioxygenase FTO is an enzyme that demethylates N(6)-methyladenosine (m(6)A) residues in mRNA in vitro and inside cells. FTO is the first RNA demethylase discovered that also serves a major regulatory function in mammals. Together with structure-based virtual screening and biochemical analyses, we report the first identification of several small-molecule inhibitors of human FTO demethylase. The most potent compound, the natural product rhein, which is neither a structural mimic of 2-oxoglutarate nor a chelator of metal ion, competitively binds to the FTO active site in vitro. Rhein also exhibits good inhibitory activity on m(6)A demethylation inside cells. These studies shed light on the development of powerful probes and new therapies for use in RNA biology and drug discovery.

Citing Articles

A novel mechanism of FTO modulating the progression of endometriosis through mediating the m6A methylation of GEF-H1 in a YTHDF1-dependent manner.

Ding X, Zhang H, Chen J, Yang M, Huang Z, Lei Y Mol Med. 2025; 31(1):78.

PMID: 40000966 PMC: 11863856. DOI: 10.1186/s10020-025-01130-8.


TDP-43/ALKBH5-mediated mA modification of CDC25A mRNA promotes glioblastoma growth by facilitating G1/S cell cycle transition.

Zhang Y, Xie S, Li W, Gu J, Zhang X, Ni B MedComm (2020). 2025; 6(3):e70108.

PMID: 39974663 PMC: 11836349. DOI: 10.1002/mco2.70108.


Therapeutic Potential of FTO Demethylase in Metabolism and Disease Pathways.

Somala C, Sathyapriya S, Bharathkumar N, Anand T, Mathangi D, Saravanan K Protein J. 2025; 44(1):21-34.

PMID: 39923206 DOI: 10.1007/s10930-025-10250-3.


Discovery of a potent PROTAC degrader for RNA demethylase FTO as antileukemic therapy.

Liu L, Qiu Y, Suo Y, Tong S, Wang Y, Zhang X Acta Pharm Sin B. 2025; 14(12):5382-5392.

PMID: 39807332 PMC: 11725161. DOI: 10.1016/j.apsb.2024.07.016.


Epigenetic Mechanisms in Osteoporosis: Exploring the Power of mA RNA Modification.

Tian S, Song Y, Guo L, Zhao H, Bai M, Miao M J Cell Mol Med. 2025; 29(1):e70344.

PMID: 39779466 PMC: 11710941. DOI: 10.1111/jcmm.70344.